Cancer researchers have successfully tested a small, engineered antibody they say shuts down growth of human glioblastoma tumors in cell and animal studies. Glioblastoma is the deadliest of brain cancers; there is no effective treatment.
Full article >>
Sunday, August 2, 2009
Antibody Targeting Of Glioblastoma Shows Promise In Preclinical Tests
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment